Poor outcomes after fibrinolytic therapy for ST-segment elevation myocardial infarction: impact of age (a meta-analysis of a decade of trials) (Q83171787)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 April 2006

Language	Label	Description	Also known as
English	Poor outcomes after fibrinolytic therapy for ST-segment elevation myocardial infarction: impact of age (a meta-analysis of a decade of trials)	scientific article published on 01 April 2006

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622607%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

0 references

Poor outcomes after fibrinolytic therapy for ST-segment elevation myocardial infarction: impact of age (a meta-analysis of a decade of trials) (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622607%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Robert P Giugliano

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622607%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Harvey D. White

6

object named as

Harvey White

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622607%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Sabina A Murphy

3

object named as

Sabina A Murphy

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622607%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Elliott M Antman

2

object named as

Elliott M Antman

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622607%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

Shaheeda Ahmed

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622607%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Christopher P Cannon

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622607%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

David A Morrow

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622607%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Eugene Braunwald

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622607%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

1 April 2006

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622607%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Journal of Thrombosis and Thrombolysis

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622607%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

21

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622607%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622607%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

119-129

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622607%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

https://scigraph.springernature.com/pub.10.1007/s11239-006-5485-9

0 references

ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction; A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the M

1 reference

https://api.crossref.org/works/10.1007%2FS11239-006-5485-9

21 January 2018

Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: findings from the Global Registry of Acute Coronary Events (GRACE)

1 reference

https://api.crossref.org/works/10.1007%2FS11239-006-5485-9

21 January 2018

Fibrinolytic therapy in patients 75 years and older with ST-segment-elevation myocardial infarction: one-year follow-up of a large prospective cohort

1 reference

https://api.crossref.org/works/10.1007%2FS11239-006-5485-9

21 January 2018

Thrombolytic therapy in older patients

1 reference

https://api.crossref.org/works/10.1007%2FS11239-006-5485-9

21 January 2018

Thrombolytic therapy for eligible elderly patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1007%2FS11239-006-5485-9

21 January 2018

Effects of age on the quality of care provided to older patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1007%2FS11239-006-5485-9

21 January 2018

Intracranial hemorrhage associated with thrombolytic therapy for elderly patients with acute myocardial infarction: results from the Cooperative Cardiovascular Project

1 reference

https://api.crossref.org/works/10.1007%2FS11239-006-5485-9

21 January 2018

Risk for intracranial hemorrhage after tissue plasminogen activator treatment for acute myocardial infarction. Participants in the National Registry of Myocardial Infarction 2.

1 reference

https://api.crossref.org/works/10.1007%2FS11239-006-5485-9

21 January 2018

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

1 reference

https://api.crossref.org/works/10.1007%2FS11239-006-5485-9

21 January 2018

Hirudin in acute myocardial infarction. Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9B trial

1 reference

https://api.crossref.org/works/10.1007%2FS11239-006-5485-9

21 January 2018

A comparison of reteplase with alteplase for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1007%2FS11239-006-5485-9

21 January 2018

A comparison of continuous infusion of alteplase with double-bolus administration for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1007%2FS11239-006-5485-9

21 January 2018

Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial

1 reference

https://api.crossref.org/works/10.1007%2FS11239-006-5485-9

21 January 2018

Intravenous NPA for the treatment of infarcting myocardium early; InTIME-II, a double-blind comparison of single-bolus lanoteplase vs accelerated alteplase for the treatment of patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1007%2FS11239-006-5485-9

21 January 2018

Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: the HERO-2 randomised trial

1 reference

https://api.crossref.org/works/10.1007%2FS11239-006-5485-9

21 January 2018

Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1007%2FS11239-006-5485-9

21 January 2018

Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial

1 reference

https://api.crossref.org/works/10.1007%2FS11239-006-5485-9

21 January 2018

Reperfusion strategies for acute myocardial infarction in the elderly: benefits and risks

1 reference

https://api.crossref.org/works/10.1007%2FS11239-006-5485-9

21 January 2018

Trends in the use of pharmacotherapies for acute myocardial infarction among physicians who design and/or implement randomized trials versus physicians in routine clinical practice: the MILIS-TIMI experience. Multicenter Investigation on Limitation

1 reference

https://api.crossref.org/works/10.1007%2FS11239-006-5485-9

21 January 2018

Acute myocardial infarction in the elderly: differences by age

1 reference

https://api.crossref.org/works/10.1007%2FS11239-006-5485-9

21 January 2018

Comparison of outcome in patients with acute myocardial infarction aged > 75 years with that in younger patients

1 reference

https://api.crossref.org/works/10.1007%2FS11239-006-5485-9

21 January 2018

Recent age-related trends in the use of thrombolytic therapy in patients who have had acute myocardial infarction. National Registry of Myocardial Infarction.

1 reference

https://api.crossref.org/works/10.1007%2FS11239-006-5485-9

21 January 2018

Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I trial. Global Utilization of Streptokinase and TPA for Occluded coronary arteries trial.

1 reference

https://api.crossref.org/works/10.1007%2FS11239-006-5485-9

21 January 2018

Epidemiology of coagulation factors, inhibitors and activation markers: the Third Glasgow MONICA Survey. I. Illustrative reference ranges by age, sex and hormone use.

1 reference

https://api.crossref.org/works/10.1007%2FS11239-006-5485-9

21 January 2018

Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications.

1 reference

https://api.crossref.org/works/10.1007%2FS11239-006-5485-9

21 January 2018

Age-related trends in short- and long-term survival after acute myocardial infarction: a 20-year population-based perspective (1975-1995).

1 reference

https://api.crossref.org/works/10.1007%2FS11239-006-5485-9

21 January 2018

Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials

1 reference

https://api.crossref.org/works/10.1007%2FS11239-006-5485-9

21 January 2018

Reperfusion therapy in elderly patients with acute myocardial infarction: a randomized comparison of primary angioplasty and thrombolytic therapy

1 reference

https://api.crossref.org/works/10.1007%2FS11239-006-5485-9

21 January 2018

A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group

1 reference

https://api.crossref.org/works/10.1007%2FS11239-006-5485-9

21 January 2018

A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1007%2FS11239-006-5485-9

21 January 2018

Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.

1 reference

https://api.crossref.org/works/10.1007%2FS11239-006-5485-9

21 January 2018

Clinical characteristics and outcome of patients with early (<2 h), intermediate (2-4 h) and late (>4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1007%2FS11239-006-5485-9

21 January 2018

Primary coronary angioplasty compared with intravenous thrombolytic therapy for acute myocardial infarction: six-month follow up and analysis of individual patient data from randomized trials

1 reference

https://api.crossref.org/works/10.1007%2FS11239-006-5485-9

21 January 2018

Angiographic and clinical characteristics associated with increased in-hospital mortality in elderly patients with acute myocardial infarction undergoing percutaneous intervention (a pooled analysis of the primary angioplasty in myocardial infarctio

1 reference

https://api.crossref.org/works/10.1007%2FS11239-006-5485-9

21 January 2018

Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation

1 reference

https://api.crossref.org/works/10.1007%2FS11239-006-5485-9

21 January 2018

Enoxaparin versus unfractionated heparin as antithrombin therapy in patients receiving fibrinolysis for ST-elevation myocardial infarction. Design and rationale for the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatmen

1 reference

https://api.crossref.org/works/10.1007%2FS11239-006-5485-9

21 January 2018

ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the M

1 reference

https://pubmed.ncbi.nlm.nih.gov/16622607

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Age-related differences in in-hospital mortality and the use of thrombolytic therapy for acute myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/16622607

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characteristics of persons dying of disease of heart: preliminary data from the 1986 National Mortality Followback Survey

1 reference

https://pubmed.ncbi.nlm.nih.gov/16622607

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised, double-blind comparison of reteplase double-bolus administration with streptokinase in acute myocardial infarction (INJECT): trial to investigate equivalence. International Joint Efficacy Comparison of Thrombolytics

1 reference

https://pubmed.ncbi.nlm.nih.gov/16622607

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collabo

1 reference

https://pubmed.ncbi.nlm.nih.gov/16622607

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction. ISIS-3 (Third International Study of Infarct S

1 reference

https://pubmed.ncbi.nlm.nih.gov/16622607

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11239-006-5485-9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622607%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622607%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q83171787&oldid=2086526357"